UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000032282 |
|---|---|
| Receipt number | R000036813 |
| Scientific Title | A phase 2 study of BOsutinib Gradual Increase as a second or third line treatment for chronic myeloid leukemia in chronic phase |
| Date of disclosure of the study information | 2018/04/18 |
| Last modified on | 2024/03/29 15:12:03 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/04/17 10:17:18 | ||
| 2 | Update | 2024/03/29 15:12:03 | Recruitment status Date of IRB |
